Northrim BanCorp
NRIM · NASDAQ
About NRIM
- Employees
- 516
- Headquarters
- Anchorage, Alaska
- Listed
- Nov 15, 1990
- Sector
- Financials
- Industry
- Banks
- Website
- ir.northrim.com
NRIM key statistics
- Market cap
- 527.65M
- Price-earnings ratio
- 7.66
- Dividend yield
- 2.77%
- Average volume
- 142.38K
- Volume
- 137.64K
- Open price
- $23.39
- High today
- $23.97
- Low today
- $23.39
- 52 Week high
- $30.82
- 52 Week low
- $20.14
Northrim BanCorp (NRIM) at a glance
As of Oct 20, 2026, Northrim BanCorp (NRIM) shares are priced at $23.72, giving the company a market cap of 527.65M, a price-to-earnings ratio of 7.66 and a dividend yield of 2.77%.
Today the stock has traded between $23.39 and $23.97. The current price is 1.4% above the day's low and 1.0% below its high.
Volume so far is 137.64K shares, in line with the average of 142.38K shares a day.
Over the past year Northrim BanCorp has ranged from $20.14 to $30.82, and now sits 34% of the way up that range.
Northrim BanCorp met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q3 FY26 it reported $0.60 per share against an estimate of $0.7089.
The average analyst price target is $31.11, 31.2% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy50.0%
- Hold50.0%
- Sell0.0%
- Low
- $30.30
- Now
- $23.72
- High
- $32.55
NRIM earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 20.8% on average.
- Q4 FY24: reported $0.4825 per share against an estimate of $0.4182
- Q1 FY25: reported $0.62 per share against an estimate of $0.4271
- Q2 FY25: reported $0.5525 per share against an estimate of $0.5789
- Q3 FY25: reported $0.60 per share against an estimate of $0.6005
- Q4 FY25: reported $0.56 per share against an estimate of $0.6732
- Q1 FY26: reported $0.63 per share against an estimate of $0.5406
- Q2 FY26: reported $0.66 per share against an estimate of $0.6222
- Q3 FY26: reported $0.60 per share against an estimate of $0.7089
NRIM news
- Press releaseGlobe Newswire
- Press releasePRNewswire
Are MGLD, NRIM, PULM Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
ACT NOW: The M&A Class Action Firm Is Investigating the Merger--LXP, LXFR, NRIM, and PULM
- Press releaseBusiness Wire
PBCO Financial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PBCO Financial Corporation - PBCO
- Press releaseBusiness Wire
NRIM Stock Alert: Halper Sadeh LLC is Investigating Whether Northrim BanCorp, Inc. is Obtaining a Fair Price for its Shareholders
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--UTZ, NEUP, SAFT, and NRIM
- Press releasePRNewswire
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
KBRA Comments on Northrim BanCorp, Inc.'s Proposed Acquisition of PBCO Financial Corporation
Similar companies
Companies in the same industry as Northrim BanCorp
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.